bluebird bio Inc
General ticker "BLUE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $836.7M
bluebird bio Inc does not follow the US Stock Market performance with the rate: -30.7%.
Estimated limits based on current volatility of 8.7%: low 7.71$, high 9.18$
Factors to consider:
- Current price 72.2% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [53.43$, 148.21$]
- 2023-12-31 to 2024-12-30 estimated range: [27.55$, 81.75$]
Financial Metrics affecting the BLUE estimates:
- Negative: Non-GAAP EPS, $ of -3.49 <= 0.10
- Negative: Operating profit margin, % of -73.11 <= 1.03
- Negative: Operating cash flow per share per price, % of -36.67 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BLUE quotes
Long-term BLUE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $3.66MM | $105.60MM | $29.50MM |
| Operating Expenses | $594.57MM | $392.69MM | $273.76MM |
| Operating Income | $-590.91MM | $-287.09MM | $-244.26MM |
| Non-Operating Income | $28.53MM | $20.63MM | $32.22MM |
| Interest Expense | $0.00MM | $6.32MM | $16.35MM |
| R&D Expense | $319.95MM | $240.76MM | $167.65MM |
| Income(Loss) | $-562.38MM | $-266.46MM | $-212.04MM |
| Taxes | $0.26MM | $0.12MM | $-0.13MM |
| Other Income(Loss) | $-256.74MM | $0.00MM | $0.00MM |
| Profit(Loss) | $-819.38MM | $-266.58MM | $-211.91MM |
| Stockholders Equity | $374.28MM | $196.34MM | $194.54MM |
| Inventory | $108.50MM | $1.41MM | $22.92MM |
| Assets | $593.79MM | $554.90MM | $619.16MM |
| Operating Cash Flow | $-635.64MM | $-352.95MM | $-235.05MM |
| Capital expenditure | $23.00MM | $13.21MM | $9.06MM |
| Investing Cash Flow | $562.56MM | $250.45MM | $154.95MM |
| Financing Cash Flow | $-93.95MM | $54.25MM | $196.25MM |
| Earnings Per Share* | $-8.16 | $-3.39 | $-1.93 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.